Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Sensei Biotherapeutics
1405 Research Blvd., Suite 125
Rockville, MD 20850
Phone: 240-243-8000
https://senseibio.com/

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company has developed a proprietary phage-based platform, ImmunoPhage, that enables the rapid generation of immune activating agents that fully engage the immune system. Using its proprietary ImmunoPhage platform, Sensei is developing a library of ImmunoPhage called Phortress targeting multiple tumor associated antigens to treat patients using a personalized yet off the shelf cocktail approach.

Key Contact
Name
John Celebi
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
01/13/21 $30,000,000 Series B Apeiron Investment Group
Cambrian Biopharma
Catalio Capital Management
Future Ventures
Moore Strategic Ventures
Presight Captial
Pura Vida Investments